Articles | Volume 11, issue 3
https://doi.org/10.5194/jbji-11-355-2026
© Author(s) 2026. This work is distributed under the Creative Commons Attribution 4.0 License.
Gram-negative prosthetic joint infections: a retrospective multicentre European study of incidence, risk factors, and treatment outcomes
Related authors
Cited articles
Anon: American Academy of Orthopaedic Surgeons EvidenceBased Clinical Practice Guideline for Diagnosis and Prevention of Periprosthetic Joint Infections, https://www.aaos.org/pjicpg (last access: 11 March 2019), 2019.
Bassetti, M., Righi, E., Pecori, D., and Tillotson, G.: Delafloxacin: An Improved Fluoroquinolone Developed through Advanced Molecular Engineering, Future Microbiol., 13, 1081–1094, https://doi.org/10.2217/fmb-2018-0067, 2018.
Casenaz, A., Piroth, L., Labattut, L., Sixt, T., Magallon, A., Guilloteau, A., Neuwirth, C., and Amoureux, L.: Epidemiology and antibiotic resistance of prosthetic joint infections according to time of occurrence, a 10-year study, J. Infect., 85, 492–498, https://doi.org/10.1016/j.jinf.2022.07.009, 2022.
Chang, Y., Li, Y., Fan, T., Jiang, K., Lv, J., and Huang, J.: Pathogenic bacteria characteristics and drug resistance in acute, delayed, and chronic periprosthetic joint infection: A retrospective analysis of 202 patients, Int. Wound J., 20, 3315–3323, https://doi.org/10.1111/iwj.14212, 2023.
Fantoni, M., Borrè, S., Rostagno, R., Riccio, G., Carrega, G., Giovannenze, F., and Taccari, F.: Epidemiological and clinical features of prosthetic joint infections caused by gram-negative bacteria, Eur. Rev. Med. Pharmacol. Sci., 23, 187–194, https://doi.org/10.26355/eurrev_201904_17490, 2019.